The present invention relates to compositions and methods for treating cardiovascular system diseases by administering to a subject soluble CTLA4 molecules that block endogenous B7 molecules from binding their ligands.

 
Web www.patentalert.com

< Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events

> Epitope directed selection of antibodies to murine tissue factor

> Secreted proteins
~ 00584